VAERS reports by lot

GSK Varicella/Shingles lot 23LD9: VAERS reports

20 VAERS reports list lot 23LD9 as a GSK Varicella/Shingles vaccine, received between 2020-02-04 and 2021-02-18. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
20
Reports
0%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2132%
Injection-site / Local reaction1726%
Dermatological (non-injection-site)1117%
Musculoskeletal58%
Neurological46%
Respiratory35%
Gastrointestinal23%
Cardiac / Cardiovascular12%
Thrombotic / Hematological12%
Allergic / Anaphylactic12%

Where reports came from

U.S. state of the reporter, where given (top 11).

Florida7
Pennsylvania2
Missouri2
Georgia2
North Carolina1
Arizona1
New Mexico1
Nebraska1
Illinois1
West Virginia1
Ohio1

Reports by month received

2020-024
2020-031
2020-042
2020-062
2020-072
2020-081
2020-093
2020-112
2020-122
2021-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.